Juno Therapeutics is a biopharmaceutical company focused on the development of clinical stage medicines for the treatment of serious diseases. The company was founded by Isabelle Rivière, Michael Jensen and Michel Sadelain in 2013 in Seattle, Washington, and was acquired by Celgene in January 2018.
Timeline
August 2014
Juno Therapeutics raises a $134,000,000 seed round from ARCH Venture Partners, Alaska Permanent Fund, Bezos Expeditions and Venrock.
April 2014
Juno Therapeutics raises a $145 series A round from ARCH Venture Partners, Alaska Permanent Fund, Bezos Expeditions and Venrock.
December 2013
Juno Therapeutics raises a $120,000,000 series A round from ARCH Venture Partners and Alaska Permanent Fund.
2013
Juno Therapeutics was founded by Isabelle Rivière, Michael Jensen, Michel Sadelain, Phil Greenberg, Renier Brentjens and Stan Riddell.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
May 20, 2021
BioSpace
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy - read this article along with other careers information, tips and advice on BioSpace
April 16, 2021
BioSpace
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma.... - read this article along with other careers information, tips and advice on BioSpace
November 9, 2020
BioSpace
Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib (BMS-986165) in Patients with Psoriatic Arthritis - read this article along with other careers information, tips and advice on BioSpace
May 20, 2020
BioSpace
Bristol Myers Squibb Research at EHA 2020 Demonstrates Continued Advances Across Multiple Blood Diseases - read this article along with other careers information, tips and advice on BioSpace
May 15, 2020
BioSpace
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Pomalyst® (pomalidomide) for AIDS-Related and HIV-Negative Kaposi Sarcoma - read this article along with other careers information, tips and advice on BioSpace
SHOW MORE
References
3
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1594864
Organization
CompanyCompany attributes
Biotechnology
Healthcare
Consumer biotechnology
Therapeutics
Biopharmaceutical
Pharmaceutical industry
Cancer
Washington (state)
Seattle
United StatesCompany Operating Status
Active
B2X
B2BCEO
Hans Bishop
Isabelle Rivière
Phil Greenberg
Michael Jensen
Michel Sadelain
Renier Brentjens
Stan RiddellParent Organization
CelgeneLegal classification
Public companyDate Incorporated
2013
Number of Employees (Ranges)
500 – 999
Full Address
400 Dexter Ave N Ste 1200 Seattle, WA, 98109-5094 United States
Place of Incorporation
Delaware
Alaska Permanent Fund
Venrock
ARCH Venture Partners
Bezos ExpeditionsIRS Number
463,656,275
Founded Date
January 1, 2013
Phone Number
+18003322056
Total Funding Amount (USD)
382,091,552
Latest Funding Round Date
October 2017
Latest Funding Type
Series A roundPatents Assigned (Count)
10
Other attributes
Headquarters
Country
Wikidata ID
Acquirer
Categories
Related Topics
Contributors
- 1
Henry Ogolla
Passionate about reading and writing. - 2
Konrad Kawka
Data extractor, syntax optimizer, English & film graduate - 3
Dawson Sewell
Writing about startups. - 4
Keeri Tramm
Accomplished manager, brand communicator, and burgeoning data analyst. - 5
Patrick Pum
A crypto enthusiast since 2018 with an aviation management educational background - 6
Jed Christiansen
Director of Product and Data at Golden || Founder - Seed-DB. - 7
Dhruv Sharma
Researcher - 8
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box. - 9
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 10
Avtandil Pirtakhiya
football player
